2d
Daily Maverick on MSNExcitement builds for long-acting TB treatments, but research still at early stageBoth TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...
Bedaquiline, the first new TB drug approved in 40 years by the USFDA, faced several challenges, including initial trial ...
Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...
TB can be found in every major city, in every country. Failing to control it threatens global health security. Now is not the ...
Globally, cases of tuberculosis have been on the rise and efforts to control it are hampered by funding shortages, according ...
Tuberculosis relapse occurs when dormant bacteria reactivate after treatment. Completing medication, maintaining immunity, ...
Pediatric TB cases are rising across Europe and Central Asia, indicating ongoing transmission and raising concern around ...
Tuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...
3d
allAfrica.com on MSNUS Aid Cut Threatens TB Treatment In NigeriaThe recent cut in U.S. aid is exacerbating Nigeria’s already wide tuberculosis (TB) funding gap, raising concerns about the ...
Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results